Ventilator-associated pneumonia (VAP) Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in a patient on mechanical ventilatory support.

Slides:



Advertisements
Similar presentations
The Eradication of VAP in Scotland Martin Hughes Nov 2010.
Advertisements

Prevention of Ventilator Associated Pneumonia
VENTILATOR ASSOCIATED PNEUMONIA
VENTILATOR – ACQUIRED PNEUMONIA Professor of Respiratory Medicine
Prevention of Lower Respiratory Tract Infections.
Wes Theurer, DO.  Recognize sepsis early  Understand therapeutic principles  Cultures before antibiotics  Crystalloid fluid resuscitation  Antimicrobials.
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Ventilator Associated Pneumonia
Ventilator Care Bundle
Healthcare Associated Pneumonia
Nosocomial Pneumonia Eliane Haron,M.D.. Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases.
Ventilator Associated Pneumonia (VAP)
Health Care Associated Pneumonia Respiratory Block
Executive Summary(4) A shorter duration of ABx therapy (7 to 8 days): recommended for - uncomplicated HAP, VAP, or HCAP - with initially appropriate therapy.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
#1005 Hospital & Community Acquired Pneumonias October 19 to October 22 Stephen Hoffmann, MD Clinical Instructor of Internal Medicine Division of Pulmonary.
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
Enoch Omonge University of Nairobi
Hospital Acquired (Nosocomial) Infections
Massimo Antonelli, MD Dept. of Intensive Care & Anesthesiology Università Cattolica del Sacro Cuore Rome - Italy Antibiotics: The old and the new.
Biofilms on Medical Devices
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
1 Telligen Quality Innovation Network- Quality Improvement Organization Ventilator Associated Events –VAE June 26, 2015 This material was prepared by Telligen,
Management of Serious MRSA Infections
Fungal pneumonia Fungal pneumonia is an infection of the lungs by fungi It can be caused by either endemic or opportunistic fungi or a combination of both.
GENERAL TEMPLATE FOR A 48”X36” POSTER Name(s) of Author(s) 1 ; Name(s) of Author(s) 2 ; Name(s) of Author(s) 3 1. Name of Institution; 2. Name on Institution;
Nosocomial infection Hospital Infection. Hospital acquired infections Nosocomial infections are those that originate or occur in a hospital or hospital-like.
Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.
Health Care Associated Pneumonia Respiratory Block BY PROF.A.M.KAMBAL and PROF.HANAN HABIB Department of Pathology, KSU.
Nosocomial Pneumonia Hospital Acquired, Ventilator Associated, Healthcare Associated Pneumonia.
Lim, Mary Lim, Phoebe Lim, Syndel Lipana, Kirk Liu, Johanna
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.
Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases per 1000 hospital admissions Incidence.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Introduction Postoperative complications are the most important factors in determining outcome in the first 72 hours following surgery It is critical.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Empirical Therapy for Ventilation Associated Pneumonia Azar. Hadadi Associate Professor of Infectious Diseases.
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
Points for Discussion Anti-Infective Drugs Advisory Committee Meeting March 5, 2003.
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals 2014 Update Dr Neda Alijani.
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Hospital-Acquired Pneumonia
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Hospital Acquired Pneumonia (HAP) By Professor Adel Khattab Prof. of Pulmonary Medicine Ain Shams University
Multi Drug- Resistant Organisms (MDRO’s) in the ICU A Guide for RT’s
ICU Nosocomial Pneumonia
Ventilator-Associated Pneumonia (VAP) An Overview for RC Students Special thanks to: Donald Dumford Donald Dumford Beth Israel Deaconess Medical Center.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
Poster template by ResearchPosters.co.za Ventilator Associated Pneumonia rates in Intensive Care. Lori J. Delaney Assistant Professor: University of Canberra,
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Anton Y. Peleg, M.B., B.S., M.P.H., and David C. Hooper, M.D. N Engl J Med 2010;362: Hospital-Acquired Infections Due to Gram-Negative Bacteria.
Ventilator-Associated Pneumonia
Hospital-Acquired Pneumonia
Hospital-acquired Pneumonia
Health Care Associated Pneumonia Respiratory Block
Health Care Associated Pneumonia
Health Care Associated Pneumonia
Health Care Associated Pneumonia Respiratory Block
Ventilator-Associated Tracheobronchitis
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
Surveillance of Post-operative pneumonia
Prophylaxis of Ventilator-Associated Pneumonia
Health Care Associated Pneumonia
Benefit of surveillance cultures at NICU
Health Care Associated Pneumonia Respiratory Block
Number of ventilator-associated pneumonia (VAP) patients with newly isolated micro-organisms from endotracheal aspirates after initiation of antibiotic.
Presentation transcript:

Ventilator-associated pneumonia (VAP) Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in a patient on mechanical ventilatory support (by endotracheal tube or tracheostomy) for >48 hours.

Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of patients receiving mechanical ventilation (MV) (other dates – 10 – 25 – – 54 % ). The mortality rate for VAP ranges from 24 to 50% and can reach 76% in some specific settings or when lung infection is caused by high-risk pathogens(crude mortality rates of 10% to 40%, attributable mortality rates of 5% to 27%).

Ethiology Staphylococcus aureus (  12,9 %) Pseudomonas aeruginosa (  17 %) Enterobacteriaceae (  9,4 %) Klebsiella spp. – (  11,6 %) Other (E. coli, Proteus spp., Acinetobacter spp., Serratia marcescens; Candida)

Pathogenesis The pathogenesis of ventilator-associated pneumonia probably involves microaspiration of oropharyngeal or gastric secretions contaminated with these organisms. The contamination source may be: Other people (cross-infection) Contaminated objects (environmental infection) Self patient (autoinfection) aspiration haematogen

Low organism resistance (age, immunosuppression) Colonization of oropharynx, gaster Gastric reflux, aspiration Necessity of longtime ventilation with possible contamination of the equipment Difficult trachea readjustment Most important factors

Early-onset ventilator-associated pneumonia (<4 days of mechanical ventilation), caused by typically antibiotic-susceptible community-acquired bacteria. Late-onset ventilator-associated pneumonia (  4 days of mechanical ventilation) caused by commonly antibiotic-resistant nosocomial organisms. Groups

Prevention Semi-Recumbent Positioning (45 *) Stress Ulcer Prophylaxis (+-) Aspiration of Subglottic Secretions (+-) Continuous Oscillation may be effective in surgical patients or patients with neurologic problems (grade I). Selective Digestive Tract Decontamination (not long time) Ventilator Circuit Management Strategies (aseptic, mucolitic) Methods of Enteral Feeding (no difference (?))

Criteria for diagnosis There are no standardized criteria for the diagnosis of ventilator- associated pneumonia, but typically three or more of the following are required: Fever Leukocytosis Purulent secretions An infiltrate on chest radiography Stricter definitions require a microbiological diagnosis as well, either by endotracheal aspirate, protected-specimen brush, or quantitative bronchoalveolar lavage

Treatment Appropriate initial empirical therapy aminoglycoside or a fluoroquinolone and a broad-spectrum betalactam antimicrobial agent Treatment based on definitive microbiologic results identifying the pathogen(s) and its susceptibility patterns

S.pneumoniae, H.influenzae, S.aureus Rann’aia P.aeruginosa, Acinetobacter spp., представителями семейства Enterobacteriaceae и реже MRSA.